483 Ascent Pharmaceuticals Nov 2015

483 Ascent Pharmaceuticals Nov 2015

Robert Horan FDA$119.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued 2 inspectional observations (via FDA 483) on 09 Nov 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 09 Nov 2015
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart